Neuroone Medical Technologies Stock Buy Hold or Sell Recommendation
| NMTC Stock | USD 0.76 0.02 2.70% |
Given the investment horizon of 90 days and your way above-average risk tolerance, our recommendation regarding Neuroone Medical Technologies is 'Strong Sell'. Macroaxis provides Neuroone Medical buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding NMTC positions.
Check out Neuroone Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as Neuroone and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Neuroone Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
Neuroone |
Execute Neuroone Medical Buy or Sell Advice
The Neuroone recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Neuroone Medical Technologies. Macroaxis does not own or have any residual interests in Neuroone Medical Technologies or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Neuroone Medical's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Extremely Dangerous | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Very regressive towards the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Sell | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Neuroone Medical Trading Alerts and Improvement Suggestions
| Neuroone Medical Tec generated a negative expected return over the last 90 days | |
| Neuroone Medical Tec has high historical volatility and very poor performance | |
| Neuroone Medical Tec has some characteristics of a very speculative penny stock | |
| The company reported the previous year's revenue of 3.45 M. Net Loss for the year was (12.32 M) with loss before overhead, payroll, taxes, and interest of (3.05 M). | |
| Neuroone Medical Technologies currently holds about 10.18 M in cash with (11.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.63. | |
| Neuroone Medical Tec has a frail financial position based on the latest SEC disclosures | |
| Roughly 16.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from insidermonkey.com: NeuroOne Medical Technologies Corporation Q4 2024 Earnings Call Transcript |
Neuroone Medical Returns Distribution Density
The distribution of Neuroone Medical's historical returns is an attempt to chart the uncertainty of Neuroone Medical's future price movements. The chart of the probability distribution of Neuroone Medical daily returns describes the distribution of returns around its average expected value. We use Neuroone Medical Technologies price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Neuroone Medical returns is essential to provide solid investment advice for Neuroone Medical.
| Mean Return | -0.17 | Value At Risk | -9.52 | Potential Upside | 10.61 | Standard Deviation | 5.63 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Neuroone Medical historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Neuroone Stock Institutional Investors
| Shares | Aurum Wealth Management Group Llc | 2024-09-30 | 12 K | Tower Research Capital Llc | 2024-09-30 | 4.3 K | Advisor Group Holdings, Inc. | 2024-09-30 | 1.3 K | Simplex Trading, Llc | 2024-09-30 | 1 K | Wells Fargo & Co | 2024-09-30 | 333 | Bank Of America Corp | 2024-09-30 | 229 | Ubs Group Ag | 2024-09-30 | 108 | Jpmorgan Chase & Co | 2024-09-30 | 69.0 | Centerpoint Advisors, Llc | 2024-06-30 | 0.0 | Vanguard Group Inc | 2024-09-30 | 919.5 K | Nantahala Capital Management, Llc | 2024-09-30 | 798.8 K |
Neuroone Medical Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 3.8M | 2.9M | 1.3M | (2.8M) | (3.9M) | (3.7M) | |
| Free Cash Flow | (3.5M) | (8.7M) | (7.8M) | (13.3M) | (11.1M) | (10.6M) | |
| Other Non Cash Items | 6.7M | 69.4K | 212.2K | 96.4K | (285.0K) | (270.7K) | |
| Capital Expenditures | 122.4K | 67.1K | 275.2K | 384.1K | 120.2K | 91.7K | |
| End Period Cash Flow | 4.0M | 6.9M | 8.2M | 5.3M | 1.5M | 1.8M | |
| Net Income | (13.6M) | (9.9M) | (10.0M) | (11.9M) | (12.3M) | (11.7M) | |
| Investments | (122.4K) | (67.1K) | (3.2M) | 2.6M | (120.2K) | (126.2K) | |
| Depreciation | 47.6K | 80.7K | 118.6K | 199.3K | 246.8K | 259.1K | |
| Change To Netincome | 1.2M | 8.7M | 1.8M | 1.1M | 1.3M | 2.2M |
Neuroone Medical Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Neuroone Medical or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Neuroone Medical's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Neuroone stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.2 | |
β | Beta against Dow Jones | 0.73 | |
σ | Overall volatility | 5.71 | |
Ir | Information ratio | -0.04 |
Neuroone Medical Volatility Alert
Neuroone Medical Technologies exhibits very low volatility with skewness of 0.87 and kurtosis of 2.1. Neuroone Medical Technologies is a potential penny stock. Although Neuroone Medical may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Neuroone Medical Technologies. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Neuroone instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Neuroone Medical Fundamentals Vs Peers
Comparing Neuroone Medical's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Neuroone Medical's direct or indirect competition across all of the common fundamentals between Neuroone Medical and the related equities. This way, we can detect undervalued stocks with similar characteristics as Neuroone Medical or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Neuroone Medical's fundamental indicators could also be used in its relative valuation, which is a method of valuing Neuroone Medical by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Neuroone Medical to competition |
| Fundamentals | Neuroone Medical | Peer Average |
| Return On Equity | -3.49 | -0.31 |
| Return On Asset | -1.43 | -0.14 |
| Operating Margin | (3.38) % | (5.51) % |
| Current Valuation | 22.18 M | 16.62 B |
| Shares Outstanding | 30.84 M | 571.82 M |
| Shares Owned By Insiders | 16.01 % | 10.09 % |
| Shares Owned By Institutions | 19.43 % | 39.21 % |
| Number Of Shares Shorted | 95.52 K | 4.71 M |
| Price To Earning | (23.53) X | 28.72 X |
| Price To Book | 28.45 X | 9.51 X |
| Price To Sales | 5.96 X | 11.42 X |
| Revenue | 3.45 M | 9.43 B |
| Gross Profit | (3.05 M) | 27.38 B |
| EBITDA | (11.84 M) | 3.9 B |
| Net Income | (12.32 M) | 570.98 M |
| Cash And Equivalents | 10.18 M | 2.7 B |
| Cash Per Share | 0.63 X | 5.01 X |
| Total Debt | 260.16 K | 5.32 B |
| Debt To Equity | 0.02 % | 48.70 % |
| Current Ratio | 13.42 X | 2.16 X |
| Book Value Per Share | 0.11 X | 1.93 K |
| Cash Flow From Operations | (11.01 M) | 971.22 M |
| Short Ratio | 0.60 X | 4.00 X |
| Earnings Per Share | (0.46) X | 3.12 X |
| Target Price | 3.15 | |
| Number Of Employees | 16 | 18.84 K |
| Beta | 0.91 | -0.15 |
| Market Capitalization | 23.38 M | 19.03 B |
| Total Asset | 5.37 M | 29.47 B |
| Retained Earnings | (75 M) | 9.33 B |
| Working Capital | 2.42 M | 1.48 B |
| Current Asset | 94.49 M | 9.34 B |
| Current Liabilities | 18.26 M | 7.9 B |
Note: Disposition of 22 shares by Rosa David A of Neuroone Medical at 1.61 subject to Rule 16b-3 [view details]
Neuroone Medical Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Neuroone . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Neuroone Medical Buy or Sell Advice
When is the right time to buy or sell Neuroone Medical Technologies? Buying financial instruments such as Neuroone Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Neuroone Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Consumer Discretionary ETFs Thematic Idea Now
Consumer Discretionary ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Consumer Discretionary ETFs theme has 29 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumer Discretionary ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Neuroone Medical Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuroone Medical. If investors know Neuroone will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuroone Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.46) | Revenue Per Share 0.158 | Quarterly Revenue Growth 0.311 | Return On Assets (1.43) | Return On Equity (3.49) |
The market value of Neuroone Medical Tec is measured differently than its book value, which is the value of Neuroone that is recorded on the company's balance sheet. Investors also form their own opinion of Neuroone Medical's value that differs from its market value or its book value, called intrinsic value, which is Neuroone Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuroone Medical's market value can be influenced by many factors that don't directly affect Neuroone Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuroone Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuroone Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuroone Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.